Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

MLA

Duncan I. Jodrell, et al. “Phase I and Clinical Evaluation of a Pharmacologically Guided Regimen of Suramin in Patients with Hormone-Refractory Prostate Cancer.” Journal of Clinical Oncology, vol. 13, Sept. 1995, pp. 2174–86. EBSCOhost, https://doi.org/10.1200/jco.1995.13.9.2174.

APA

Duncan I. Jodrell, S C Jacobs, Eleanor G. Zuhowski, Katherine Tkaczuk, Ramzi K. Hemady, Mario A. Eisenberger, M H Lowitt, V. J. Sinibaldi, Rajeshwari Sridhara, & Leonard M. Reyno. (1995). Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer. Journal of Clinical Oncology, 13, 2174–2186. https://doi.org/10.1200/jco.1995.13.9.2174

Chicago

Duncan I. Jodrell, S C Jacobs, Eleanor G. Zuhowski, Katherine Tkaczuk, Ramzi K. Hemady, Mario A. Eisenberger, M H Lowitt, V. J. Sinibaldi, Rajeshwari Sridhara, and Leonard M. Reyno. 1995. “Phase I and Clinical Evaluation of a Pharmacologically Guided Regimen of Suramin in Patients with Hormone-Refractory Prostate Cancer.” Journal of Clinical Oncology 13 (September): 2174–86. doi:10.1200/jco.1995.13.9.2174.